Care home medicines case: cartel enforcement lessons
- Competition and Markets Authority
- Part of:
- Competition law compliance: guidance for businesses and Competition Act and cartels
- First published:
- 14 April 2015
Lessons learned from the care home medicines case about cartel enforcement and compliance with the law.
PDF, 589KB, 1 page
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
In 2014, 2 pharmaceutical companies were found to have entered into an illegal market-sharing agreement which resulted in fines of over £370,000.
Market sharing is a serious form of cartel activity that can damage the economy and cause consumer harm.
This document sets out what lessons can be learned from the case and what businesses can do to make sure they comply with the law.
Published: 14 April 2015